Web Results

www.ftc.gov/enforcement/cases-proceedings/141-0134/sun-pharmaceutical-industries-ltd-et-al-matter

Mar 20, 2015 ... Torrent Pharmaceuticals Ltd., a global drug company based in India that markets generic drugs in the United States, will acquire the divested ...

www.bloomberg.com/news/articles/2018-07-19/novartis-sues-in-bid-to-block-generic-sales-of-best-selling-drug

Jul 19, 2018 ... Teva Pharmaceuticals USA Inc., 18-cv-1039; Novartis Pharmaceuticals Corporation v. Sun Pharmaceutical Industries Ltd., 18-cv-1040; and ...

economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/sun-rises-with-rd-and-bets-on-specialty-drugs/articleshow/64458050.cms

Jun 5, 2018 ... Sun Pharma- India's largest drug maker - is vying for its share in the ... When ET sought responses on its strategy, Sun Pharma the company ... Novartis, Eli Lilly are ensconced in the drug segment and Sun is ... area for a small entry into the US branded or specialty drugs business. .... Ltd. All rights reserved.

www.sunpharma.com/Media/Press-Releases/Press%20Release%20Sun%20Pharma%20to%20acquire%20branded%20oncology%20product%20Odomzo%C2%AE%20for%20global%20markets.pdf

Dec 22, 2016 ... ... BSE: 524715, Sun Pharmaceutical Industries Ltd and includes its subsidiaries or associate companies today announced its plans to acquire a branded oncology product, Odomzo, from Novartis. The ... pharmaceutical company and India's top pharmaceutical company. A ... 1 Dummer R et al, ASCO 2016.

www.barentskrans.nl/en/news/final-relief-judgment-enforcement-second-medical-use-patent

Apr 10, 2017 ... Novartis et al. ... In 2013, Sun won a tender organised by health insurance company VGZ ... In its final decision of 5 April, the District Court held that Novartis' patent had however been directly infringed because Sun knew, or in ...

www.law360.com/companies/sun-pharmaceutical

Ranbaxy merged into Sun Pharmaceutical Industries Ltd. in 2015... June 5, 2018 Don't ... August 9, 2018 | Louisiana Eastern Dannhardt et al v. Sanofi US ...

www.wsj.com/articles/sun-pharma-to-buy-japanese-brands-from-novartis-in-293-million-deal-1459274146

March 29, 2016 1:55 p.m. ET. 0 COMMENTS. Sun Pharmaceutical Industries Ltd. EQSUNPHARMA -0.40% said it had agreed to buy 14 ... million cash deal that would expand the Indian company's footprint into Japan. ... Under the terms of the agreements, Novartis will continue to distribute the brands pending transfer of all  ...

www.pharmasalmanac.com/articles/sun-pharma-announces-twelve-tildrakizumab-abstracts-to-be-presented-at-american-academy-of-dermatology-2018-annual-meeting

Feb 15, 2018 ... 12, 2018 /PRNewswire/ — Sun Pharmaceutical Industries Ltd. (Reuters: SUN. ... SUNPHARMA, BSE: 524715, "Sun Pharma" and includes its subsidiaries and/or .... Funded by a Sun Pharma subsidiary, Merck & Co., Inc., Kenilworth, NJ, USA is ... Menter A, Gottlieb A, Feldman SR, Van Voorhees AS et al.

patentdocs.typepad.com/files/sun-pharma_ipr2017-01929_institution.pdf

... INC., and. SUN PHARMA GLOBAL FZE,. Petitioner, v. NOVARTIS AG,. Patent Owner. ... Sun Pharmaceutical Industries, Ltd., Sun Pharmaceutical Industries,. Inc., and Sun ... In IPR2017-00854, Apotex, Inc. and Apotex Corp. (collectively, ... 5 Kappos et al., “A Placebo-Controlled Trial of Oral Fingolimod in Relapsing ...